Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXZZ1K
|
||||
| Drug Name |
N-((S)-3-(7,7-dimethylbicyclo[2.2.1]heptan-1-yl)-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-1-oxopropan-2-yl)morpholine-4-carboxamide
|
||||
| Synonyms |
CHEMBL1807702
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C29H43N5O6S
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CC23CCC(CC2)C3(C)C)NC(=O)N4CCOCC4)C(=O)CN1S(=O)(=O)c5ccccn5
|
||||
| InChI |
InChI=1S/C29H43N5O6S/c1-20-7-8-22(24(35)19-34(20)41(38,39)25-6-4-5-13-30-25)31-26(36)23(32-27(37)33-14-16-40-17-15-33)18-29-11-9-21(10-12-29)28(29,2)3/h4-6,13,20-23H,7-12,14-19H2,1-3H3,(H,31,36)(H,32,37)/t20-,21?,22+,23+,29?/m1/s1
|
||||
| InChIKey |
WTCANZGRFGLWSN-LUYDZRCASA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.